Embolotherapy Industry Research Report 2023
Highlights
The global Embolotherapy market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for Embolotherapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Asia-Pacific market for Embolotherapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
The major global companies of Embolotherapy include Medtronic, Boston Scientific, Terumo, Penumbra, Inc., Johnson & Johnson, Sirtex, Merit Medical, Varian and Stryker, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for Embolotherapy in Cancer is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Microspheres for Embolization, which accounted for % of the global market of Embolotherapy in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Embolotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Embolotherapy.
The Embolotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Embolotherapy market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Embolotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Embolotherapy type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Embolotherapy are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Embolotherapy segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Embolotherapy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Embolotherapy market.
Embolotherapy Segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Embolotherapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Embolotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Embolotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Embolotherapy industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Embolotherapy.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Embolotherapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
The global Embolotherapy market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for Embolotherapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Asia-Pacific market for Embolotherapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
The major global companies of Embolotherapy include Medtronic, Boston Scientific, Terumo, Penumbra, Inc., Johnson & Johnson, Sirtex, Merit Medical, Varian and Stryker, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for Embolotherapy in Cancer is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Microspheres for Embolization, which accounted for % of the global market of Embolotherapy in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Embolotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Embolotherapy.
The Embolotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Embolotherapy market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Embolotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Medtronic
- Boston Scientific
- Terumo
- Penumbra, Inc.
- Johnson & Johnson
- Sirtex
- Merit Medical
- Varian
- Stryker
- Jiangsu Hengrui Pharmaceuticals Co., Ltd
- Cook Medical
- Kaneka
- Meril Life Sciences
- Peijia Medical Limited
- Wallaby Medical
- MicroPort Scientific Corporation
- Shandong Visee Medical Devices Co.,Ltd
- Beijing Taijie Weiye Technology
Global markets are presented by Embolotherapy type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Embolotherapy are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Embolotherapy segment by Type
- Microspheres for Embolization
- Embolism Particles
- Embolic coils
- Liquid Embolic Agent
- Auxiliary Embolization Material
- Others
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Embolotherapy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Embolotherapy market.
Embolotherapy Segment by Application
- Cancer
- Peripheral Aascular Disease
- Nerve System Disease
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Embolotherapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Embolotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Embolotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Embolotherapy industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Embolotherapy.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Embolotherapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Embolotherapy by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Microspheres for Embolization
1.2.3 Embolism Particles
1.2.4 Embolic coils
1.2.5 Liquid Embolic Agent
1.2.6 Auxiliary Embolization Material
1.2.7 Others
2.3 Embolotherapy by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Cancer
2.3.3 Peripheral Aascular Disease
2.3.4 Nerve System Disease
2.3.5 Others
2.4 Assumptions and Limitations
3 EMBOLOTHERAPY BREAKDOWN DATA BY TYPE
3.1 Global Embolotherapy Historic Market Size by Type (2018-2023)
3.2 Global Embolotherapy Forecasted Market Size by Type (2023-2028)
4 EMBOLOTHERAPY BREAKDOWN DATA BY APPLICATION
4.1 Global Embolotherapy Historic Market Size by Application (2018-2023)
4.2 Global Embolotherapy Forecasted Market Size by Application (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Embolotherapy Market Perspective (2018-2029)
5.2 Global Embolotherapy Growth Trends by Region
5.2.1 Global Embolotherapy Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Embolotherapy Historic Market Size by Region (2018-2023)
5.2.3 Embolotherapy Forecasted Market Size by Region (2024-2029)
5.3 Embolotherapy Market Dynamics
5.3.1 Embolotherapy Industry Trends
5.3.2 Embolotherapy Market Drivers
5.3.3 Embolotherapy Market Challenges
5.3.4 Embolotherapy Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Embolotherapy Players by Revenue
6.1.1 Global Top Embolotherapy Players by Revenue (2018-2023)
6.1.2 Global Embolotherapy Revenue Market Share by Players (2018-2023)
6.2 Global Embolotherapy Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Embolotherapy Head office and Area Served
6.4 Global Embolotherapy Players, Product Type & Application
6.5 Global Embolotherapy Players, Date of Enter into This Industry
6.6 Global Embolotherapy Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Embolotherapy Market Size (2018-2029)
7.2 North America Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Embolotherapy Market Size by Country (2018-2023)
7.4 North America Embolotherapy Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Embolotherapy Market Size (2018-2029)
8.2 Europe Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Embolotherapy Market Size by Country (2018-2023)
8.4 Europe Embolotherapy Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Embolotherapy Market Size (2018-2029)
9.2 Asia-Pacific Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Embolotherapy Market Size by Country (2018-2023)
9.4 Asia-Pacific Embolotherapy Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Embolotherapy Market Size (2018-2029)
10.2 Latin America Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Embolotherapy Market Size by Country (2018-2023)
10.4 Latin America Embolotherapy Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Embolotherapy Market Size (2018-2029)
11.2 Middle East & Africa Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Embolotherapy Market Size by Country (2018-2023)
11.4 Middle East & Africa Embolotherapy Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Embolotherapy Introduction
11.1.4 Medtronic Revenue in Embolotherapy Business (2017-2022)
11.1.5 Medtronic Recent Development
11.2 Boston Scientific
11.2.1 Boston Scientific Company Detail
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Embolotherapy Introduction
11.2.4 Boston Scientific Revenue in Embolotherapy Business (2017-2022)
11.2.5 Boston Scientific Recent Development
11.3 Terumo
11.3.1 Terumo Company Detail
11.3.2 Terumo Business Overview
11.3.3 Terumo Embolotherapy Introduction
11.3.4 Terumo Revenue in Embolotherapy Business (2017-2022)
11.3.5 Terumo Recent Development
11.4 Penumbra, Inc.
11.4.1 Penumbra, Inc. Company Detail
11.4.2 Penumbra, Inc. Business Overview
11.4.3 Penumbra, Inc. Embolotherapy Introduction
11.4.4 Penumbra, Inc. Revenue in Embolotherapy Business (2017-2022)
11.4.5 Penumbra, Inc. Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Embolotherapy Introduction
11.5.4 Johnson & Johnson Revenue in Embolotherapy Business (2017-2022)
11.5.5 Johnson & Johnson Recent Development
11.6 Sirtex
11.6.1 Sirtex Company Detail
11.6.2 Sirtex Business Overview
11.6.3 Sirtex Embolotherapy Introduction
11.6.4 Sirtex Revenue in Embolotherapy Business (2017-2022)
11.6.5 Sirtex Recent Development
11.7 Merit Medical
11.7.1 Merit Medical Company Detail
11.7.2 Merit Medical Business Overview
11.7.3 Merit Medical Embolotherapy Introduction
11.7.4 Merit Medical Revenue in Embolotherapy Business (2017-2022)
11.7.5 Merit Medical Recent Development
11.8 Varian
11.8.1 Varian Company Detail
11.8.2 Varian Business Overview
11.8.3 Varian Embolotherapy Introduction
11.8.4 Varian Revenue in Embolotherapy Business (2017-2022)
11.8.5 Varian Recent Development
11.9 Stryker
11.9.1 Stryker Company Detail
11.9.2 Stryker Business Overview
11.9.3 Stryker Embolotherapy Introduction
11.9.4 Stryker Revenue in Embolotherapy Business (2017-2022)
11.9.5 Stryker Recent Development
11.10 Jiangsu Hengrui Pharmaceuticals Co., Ltd
11.10.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Company Detail
11.10.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Business Overview
11.10.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Introduction
11.10.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Revenue in Embolotherapy Business (2017-2022)
11.10.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Development
11.11 Cook Medical
11.11.1 Cook Medical Company Detail
11.11.2 Cook Medical Business Overview
11.11.3 Cook Medical Embolotherapy Introduction
11.11.4 Cook Medical Revenue in Embolotherapy Business (2017-2022)
11.11.5 Cook Medical Recent Development
11.12 Kaneka
11.12.1 Kaneka Company Detail
11.12.2 Kaneka Business Overview
11.12.3 Kaneka Embolotherapy Introduction
11.12.4 Kaneka Revenue in Embolotherapy Business (2017-2022)
11.12.5 Kaneka Recent Development
11.13 Meril Life Sciences
11.13.1 Meril Life Sciences Company Detail
11.13.2 Meril Life Sciences Business Overview
11.13.3 Meril Life Sciences Embolotherapy Introduction
11.13.4 Meril Life Sciences Revenue in Embolotherapy Business (2017-2022)
11.13.5 Meril Life Sciences Recent Development
11.14 Peijia Medical Limited
11.14.1 Peijia Medical Limited Company Detail
11.14.2 Peijia Medical Limited Business Overview
11.14.3 Peijia Medical Limited Embolotherapy Introduction
11.14.4 Peijia Medical Limited Revenue in Embolotherapy Business (2017-2022)
11.14.5 Peijia Medical Limited Recent Development
11.15 Wallaby Medical
11.15.1 Wallaby Medical Company Detail
11.15.2 Wallaby Medical Business Overview
11.15.3 Wallaby Medical Embolotherapy Introduction
11.15.4 Wallaby Medical Revenue in Embolotherapy Business (2017-2022)
11.15.5 Wallaby Medical Recent Development
11.16 MicroPort Scientific Corporation
11.16.1 MicroPort Scientific Corporation Company Detail
11.16.2 MicroPort Scientific Corporation Business Overview
11.16.3 MicroPort Scientific Corporation Embolotherapy Introduction
11.16.4 MicroPort Scientific Corporation Revenue in Embolotherapy Business (2017-2022)
11.16.5 MicroPort Scientific Corporation Recent Development
11.17 Shandong Visee Medical Devices Co.,Ltd
11.17.1 Shandong Visee Medical Devices Co.,Ltd Company Detail
11.17.2 Shandong Visee Medical Devices Co.,Ltd Business Overview
11.17.3 Shandong Visee Medical Devices Co.,Ltd Embolotherapy Introduction
11.17.4 Shandong Visee Medical Devices Co.,Ltd Revenue in Embolotherapy Business (2017-2022)
11.17.5 Shandong Visee Medical Devices Co.,Ltd Recent Development
11.18 Beijing Taijie Weiye Technology
11.18.1 Beijing Taijie Weiye Technology Company Detail
11.18.2 Beijing Taijie Weiye Technology Business Overview
11.18.3 Beijing Taijie Weiye Technology Embolotherapy Introduction
11.18.4 Beijing Taijie Weiye Technology Revenue in Embolotherapy Business (2017-2022)
11.18.5 Beijing Taijie Weiye Technology Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Embolotherapy by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Microspheres for Embolization
1.2.3 Embolism Particles
1.2.4 Embolic coils
1.2.5 Liquid Embolic Agent
1.2.6 Auxiliary Embolization Material
1.2.7 Others
2.3 Embolotherapy by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Cancer
2.3.3 Peripheral Aascular Disease
2.3.4 Nerve System Disease
2.3.5 Others
2.4 Assumptions and Limitations
3 EMBOLOTHERAPY BREAKDOWN DATA BY TYPE
3.1 Global Embolotherapy Historic Market Size by Type (2018-2023)
3.2 Global Embolotherapy Forecasted Market Size by Type (2023-2028)
4 EMBOLOTHERAPY BREAKDOWN DATA BY APPLICATION
4.1 Global Embolotherapy Historic Market Size by Application (2018-2023)
4.2 Global Embolotherapy Forecasted Market Size by Application (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Embolotherapy Market Perspective (2018-2029)
5.2 Global Embolotherapy Growth Trends by Region
5.2.1 Global Embolotherapy Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Embolotherapy Historic Market Size by Region (2018-2023)
5.2.3 Embolotherapy Forecasted Market Size by Region (2024-2029)
5.3 Embolotherapy Market Dynamics
5.3.1 Embolotherapy Industry Trends
5.3.2 Embolotherapy Market Drivers
5.3.3 Embolotherapy Market Challenges
5.3.4 Embolotherapy Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Embolotherapy Players by Revenue
6.1.1 Global Top Embolotherapy Players by Revenue (2018-2023)
6.1.2 Global Embolotherapy Revenue Market Share by Players (2018-2023)
6.2 Global Embolotherapy Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Embolotherapy Head office and Area Served
6.4 Global Embolotherapy Players, Product Type & Application
6.5 Global Embolotherapy Players, Date of Enter into This Industry
6.6 Global Embolotherapy Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Embolotherapy Market Size (2018-2029)
7.2 North America Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Embolotherapy Market Size by Country (2018-2023)
7.4 North America Embolotherapy Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Embolotherapy Market Size (2018-2029)
8.2 Europe Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Embolotherapy Market Size by Country (2018-2023)
8.4 Europe Embolotherapy Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Embolotherapy Market Size (2018-2029)
9.2 Asia-Pacific Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Embolotherapy Market Size by Country (2018-2023)
9.4 Asia-Pacific Embolotherapy Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Embolotherapy Market Size (2018-2029)
10.2 Latin America Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Embolotherapy Market Size by Country (2018-2023)
10.4 Latin America Embolotherapy Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Embolotherapy Market Size (2018-2029)
11.2 Middle East & Africa Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Embolotherapy Market Size by Country (2018-2023)
11.4 Middle East & Africa Embolotherapy Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Embolotherapy Introduction
11.1.4 Medtronic Revenue in Embolotherapy Business (2017-2022)
11.1.5 Medtronic Recent Development
11.2 Boston Scientific
11.2.1 Boston Scientific Company Detail
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Embolotherapy Introduction
11.2.4 Boston Scientific Revenue in Embolotherapy Business (2017-2022)
11.2.5 Boston Scientific Recent Development
11.3 Terumo
11.3.1 Terumo Company Detail
11.3.2 Terumo Business Overview
11.3.3 Terumo Embolotherapy Introduction
11.3.4 Terumo Revenue in Embolotherapy Business (2017-2022)
11.3.5 Terumo Recent Development
11.4 Penumbra, Inc.
11.4.1 Penumbra, Inc. Company Detail
11.4.2 Penumbra, Inc. Business Overview
11.4.3 Penumbra, Inc. Embolotherapy Introduction
11.4.4 Penumbra, Inc. Revenue in Embolotherapy Business (2017-2022)
11.4.5 Penumbra, Inc. Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Embolotherapy Introduction
11.5.4 Johnson & Johnson Revenue in Embolotherapy Business (2017-2022)
11.5.5 Johnson & Johnson Recent Development
11.6 Sirtex
11.6.1 Sirtex Company Detail
11.6.2 Sirtex Business Overview
11.6.3 Sirtex Embolotherapy Introduction
11.6.4 Sirtex Revenue in Embolotherapy Business (2017-2022)
11.6.5 Sirtex Recent Development
11.7 Merit Medical
11.7.1 Merit Medical Company Detail
11.7.2 Merit Medical Business Overview
11.7.3 Merit Medical Embolotherapy Introduction
11.7.4 Merit Medical Revenue in Embolotherapy Business (2017-2022)
11.7.5 Merit Medical Recent Development
11.8 Varian
11.8.1 Varian Company Detail
11.8.2 Varian Business Overview
11.8.3 Varian Embolotherapy Introduction
11.8.4 Varian Revenue in Embolotherapy Business (2017-2022)
11.8.5 Varian Recent Development
11.9 Stryker
11.9.1 Stryker Company Detail
11.9.2 Stryker Business Overview
11.9.3 Stryker Embolotherapy Introduction
11.9.4 Stryker Revenue in Embolotherapy Business (2017-2022)
11.9.5 Stryker Recent Development
11.10 Jiangsu Hengrui Pharmaceuticals Co., Ltd
11.10.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Company Detail
11.10.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Business Overview
11.10.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Introduction
11.10.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Revenue in Embolotherapy Business (2017-2022)
11.10.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Development
11.11 Cook Medical
11.11.1 Cook Medical Company Detail
11.11.2 Cook Medical Business Overview
11.11.3 Cook Medical Embolotherapy Introduction
11.11.4 Cook Medical Revenue in Embolotherapy Business (2017-2022)
11.11.5 Cook Medical Recent Development
11.12 Kaneka
11.12.1 Kaneka Company Detail
11.12.2 Kaneka Business Overview
11.12.3 Kaneka Embolotherapy Introduction
11.12.4 Kaneka Revenue in Embolotherapy Business (2017-2022)
11.12.5 Kaneka Recent Development
11.13 Meril Life Sciences
11.13.1 Meril Life Sciences Company Detail
11.13.2 Meril Life Sciences Business Overview
11.13.3 Meril Life Sciences Embolotherapy Introduction
11.13.4 Meril Life Sciences Revenue in Embolotherapy Business (2017-2022)
11.13.5 Meril Life Sciences Recent Development
11.14 Peijia Medical Limited
11.14.1 Peijia Medical Limited Company Detail
11.14.2 Peijia Medical Limited Business Overview
11.14.3 Peijia Medical Limited Embolotherapy Introduction
11.14.4 Peijia Medical Limited Revenue in Embolotherapy Business (2017-2022)
11.14.5 Peijia Medical Limited Recent Development
11.15 Wallaby Medical
11.15.1 Wallaby Medical Company Detail
11.15.2 Wallaby Medical Business Overview
11.15.3 Wallaby Medical Embolotherapy Introduction
11.15.4 Wallaby Medical Revenue in Embolotherapy Business (2017-2022)
11.15.5 Wallaby Medical Recent Development
11.16 MicroPort Scientific Corporation
11.16.1 MicroPort Scientific Corporation Company Detail
11.16.2 MicroPort Scientific Corporation Business Overview
11.16.3 MicroPort Scientific Corporation Embolotherapy Introduction
11.16.4 MicroPort Scientific Corporation Revenue in Embolotherapy Business (2017-2022)
11.16.5 MicroPort Scientific Corporation Recent Development
11.17 Shandong Visee Medical Devices Co.,Ltd
11.17.1 Shandong Visee Medical Devices Co.,Ltd Company Detail
11.17.2 Shandong Visee Medical Devices Co.,Ltd Business Overview
11.17.3 Shandong Visee Medical Devices Co.,Ltd Embolotherapy Introduction
11.17.4 Shandong Visee Medical Devices Co.,Ltd Revenue in Embolotherapy Business (2017-2022)
11.17.5 Shandong Visee Medical Devices Co.,Ltd Recent Development
11.18 Beijing Taijie Weiye Technology
11.18.1 Beijing Taijie Weiye Technology Company Detail
11.18.2 Beijing Taijie Weiye Technology Business Overview
11.18.3 Beijing Taijie Weiye Technology Embolotherapy Introduction
11.18.4 Beijing Taijie Weiye Technology Revenue in Embolotherapy Business (2017-2022)
11.18.5 Beijing Taijie Weiye Technology Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Embolotherapy Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Embolotherapy Revenue Market Share by Type (2018-2023)
Table 7. Global Embolotherapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Embolotherapy Revenue Market Share by Type (2024-2029)
Table 9. Global Embolotherapy Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Embolotherapy Revenue Market Share by Application (2018-2023)
Table 11. Global Embolotherapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Embolotherapy Revenue Market Share by Application (2024-2029)
Table 13. Global Embolotherapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Embolotherapy Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Embolotherapy Market Share by Region (2018-2023)
Table 16. Global Embolotherapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Embolotherapy Market Share by Region (2024-2029)
Table 18. Embolotherapy Market Trends
Table 19. Embolotherapy Market Drivers
Table 20. Embolotherapy Market Challenges
Table 21. Embolotherapy Market Restraints
Table 22. Global Top Embolotherapy Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Embolotherapy Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Embolotherapy Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Embolotherapy, Headquarters and Area Served
Table 26. Global Embolotherapy Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Embolotherapy by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Embolotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Embolotherapy Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Embolotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Embolotherapy Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Embolotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Embolotherapy Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Embolotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Embolotherapy Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Embolotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Embolotherapy Market Size by Country (2024-2029) & (US$ Million)
Table 45. Medtronic Company Detail
Table 46. Medtronic Business Overview
Table 47. Medtronic Embolotherapy Product
Table 48. Medtronic Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 49. Medtronic Recent Development
Table 50. Boston Scientific Company Detail
Table 51. Boston Scientific Business Overview
Table 52. Boston Scientific Embolotherapy Product
Table 53. Boston Scientific Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 54. Boston Scientific Recent Development
Table 55. Terumo Company Detail
Table 56. Terumo Business Overview
Table 57. Terumo Embolotherapy Product
Table 58. Terumo Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 59. Terumo Recent Development
Table 60. Penumbra, Inc. Company Detail
Table 61. Penumbra, Inc. Business Overview
Table 62. Penumbra, Inc. Embolotherapy Product
Table 63. Penumbra, Inc. Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 64. Penumbra, Inc. Recent Development
Table 65. Johnson & Johnson Company Detail
Table 66. Johnson & Johnson Business Overview
Table 67. Johnson & Johnson Embolotherapy Product
Table 68. Johnson & Johnson Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 69. Johnson & Johnson Recent Development
Table 70. Sirtex Company Detail
Table 71. Sirtex Business Overview
Table 72. Sirtex Embolotherapy Product
Table 73. Sirtex Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 74. Sirtex Recent Development
Table 75. Merit Medical Company Detail
Table 76. Merit Medical Business Overview
Table 77. Merit Medical Embolotherapy Product
Table 78. Merit Medical Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 79. Merit Medical Recent Development
Table 80. Varian Company Detail
Table 81. Varian Business Overview
Table 82. Varian Embolotherapy Product
Table 83. Varian Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 84. Varian Recent Development
Table 85. Stryker Company Detail
Table 86. Stryker Business Overview
Table 87. Stryker Embolotherapy Product
Table 88. Stryker Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 89. Stryker Recent Development
Table 90. Jiangsu Hengrui Pharmaceuticals Co., Ltd Company Detail
Table 91. Jiangsu Hengrui Pharmaceuticals Co., Ltd Business Overview
Table 92. Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Product
Table 93. Jiangsu Hengrui Pharmaceuticals Co., Ltd Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 94. Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Development
Table 95. Cook Medical Company Detail
Table 96. Cook Medical Business Overview
Table 97. Cook Medical EmbolotherapyProduct
Table 98. Cook Medical Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 99. Cook Medical Recent Development
Table 100. Kaneka Company Detail
Table 101. Kaneka Business Overview
Table 102. Kaneka EmbolotherapyProduct
Table 103. Kaneka Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 104. Kaneka Recent Development
Table 105. Meril Life Sciences Company Detail
Table 106. Meril Life Sciences Business Overview
Table 107. Meril Life Sciences EmbolotherapyProduct
Table 108. Meril Life Sciences Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 109. Meril Life Sciences Recent Development
Table 110. Peijia Medical Limited Company Detail
Table 111. Peijia Medical Limited Business Overview
Table 112. Peijia Medical Limited EmbolotherapyProduct
Table 113. Peijia Medical Limited Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 114. Peijia Medical Limited Recent Development
Table 115. Wallaby Medical Company Detail
Table 116. Wallaby Medical Business Overview
Table 117. Wallaby Medical EmbolotherapyProduct
Table 118. Wallaby Medical Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 119. Wallaby Medical Recent Development
Table 120. MicroPort Scientific Corporation Company Detail
Table 121. MicroPort Scientific Corporation Business Overview
Table 122. MicroPort Scientific Corporation EmbolotherapyProduct
Table 123. MicroPort Scientific Corporation Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 124. MicroPort Scientific Corporation Recent Development
Table 125. Shandong Visee Medical Devices Co.,Ltd Company Detail
Table 126. Shandong Visee Medical Devices Co.,Ltd Business Overview
Table 127. Shandong Visee Medical Devices Co.,Ltd EmbolotherapyProduct
Table 128. Shandong Visee Medical Devices Co.,Ltd Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 129. Shandong Visee Medical Devices Co.,Ltd Recent Development
Table 130. Beijing Taijie Weiye Technology Company Detail
Table 131. Beijing Taijie Weiye Technology Business Overview
Table 132. Beijing Taijie Weiye Technology EmbolotherapyProduct
Table 133. Beijing Taijie Weiye Technology Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 134. Beijing Taijie Weiye Technology Recent Development
Table 135. Medtronic Company Information
Table 136. Medtronic Business Overview
Table 137. Medtronic Embolotherapy Revenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 138. Medtronic Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 139. Medtronic Recent Development
Table 140. Boston Scientific Company Information
Table 141. Boston Scientific Business Overview
Table 142. Boston Scientific Embolotherapy Revenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 143. Boston Scientific Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 144. Boston Scientific Recent Development
Table 145. Terumo Company Information
Table 146. Terumo Business Overview
Table 147. Terumo Embolotherapy Revenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 148. Terumo Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 149. Terumo Recent Development
Table 150. Penumbra, Inc. Company Information
Table 151. Penumbra, Inc. Business Overview
Table 152. Penumbra, Inc. Embolotherapy Revenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 153. Penumbra, Inc. Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 154. Penumbra, Inc. Recent Development
Table 155. Johnson & Johnson Company Information
Table 156. Johnson & Johnson Business Overview
Table 157. Johnson & Johnson Embolotherapy Revenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 158. Johnson & Johnson Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 159. Johnson & Johnson Recent Development
Table 160. Sirtex Company Information
Table 161. Sirtex Business Overview
Table 162. Sirtex Embolotherapy Revenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 163. Sirtex Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 164. Sirtex Recent Development
Table 165. Merit Medical Company Information
Table 166. Merit Medical Business Overview
Table 167. Merit Medical Embolotherapy Revenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 168. Merit Medical Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 169. Merit Medical Recent Development
Table 170. Varian Company Information
Table 171. Varian Business Overview
Table 172. Varian Embolotherapy Revenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 173. Varian Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 174. Varian Recent Development
Table 175. Stryker Company Information
Table 176. Stryker Business Overview
Table 177. Stryker Embolotherapy Revenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 178. Stryker Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 179. Stryker Recent Development
Table 180. Jiangsu Hengrui Pharmaceuticals Co., Ltd Company Information
Table 181. Jiangsu Hengrui Pharmaceuticals Co., Ltd Business Overview
Table 182. Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Revenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 183. Jiangsu Hengrui Pharmaceuticals Co., Ltd Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 184. Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Development
Table 185. Cook Medical Company Information
Table 186. Cook Medical Business Overview
Table 187. Cook Medical EmbolotherapyRevenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 188. Cook Medical Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 189. Cook Medical Recent Development
Table 190. Kaneka Company Information
Table 191. Kaneka Business Overview
Table 192. Kaneka EmbolotherapyRevenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 193. Kaneka Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 194. Kaneka Recent Development
Table 195. Meril Life Sciences Company Information
Table 196. Meril Life Sciences Business Overview
Table 197. Meril Life Sciences EmbolotherapyRevenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 198. Meril Life Sciences Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 199. Meril Life Sciences Recent Development
Table 200. Peijia Medical Limited Company Information
Table 201. Peijia Medical Limited Business Overview
Table 202. Peijia Medical Limited EmbolotherapyRevenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 203. Peijia Medical Limited Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 204. Peijia Medical Limited Recent Development
Table 205. Wallaby Medical Company Information
Table 206. Wallaby Medical Business Overview
Table 207. Wallaby Medical EmbolotherapyRevenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 208. Wallaby Medical Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 209. Wallaby Medical Recent Development
Table 210. MicroPort Scientific Corporation Company Information
Table 211. MicroPort Scientific Corporation Business Overview
Table 212. MicroPort Scientific Corporation EmbolotherapyRevenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 213. MicroPort Scientific Corporation Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 214. MicroPort Scientific Corporation Recent Development
Table 215. Shandong Visee Medical Devices Co.,Ltd Company Information
Table 216. Shandong Visee Medical Devices Co.,Ltd Business Overview
Table 217. Shandong Visee Medical Devices Co.,Ltd EmbolotherapyRevenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 218. Shandong Visee Medical Devices Co.,Ltd Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 219. Shandong Visee Medical Devices Co.,Ltd Recent Development
Table 220. Beijing Taijie Weiye Technology Company Information
Table 221. Beijing Taijie Weiye Technology Business Overview
Table 222. Beijing Taijie Weiye Technology EmbolotherapyRevenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 223. Beijing Taijie Weiye Technology Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Embolotherapy Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Embolotherapy Revenue Market Share by Type (2018-2023)
Table 7. Global Embolotherapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Embolotherapy Revenue Market Share by Type (2024-2029)
Table 9. Global Embolotherapy Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Embolotherapy Revenue Market Share by Application (2018-2023)
Table 11. Global Embolotherapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Embolotherapy Revenue Market Share by Application (2024-2029)
Table 13. Global Embolotherapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Embolotherapy Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Embolotherapy Market Share by Region (2018-2023)
Table 16. Global Embolotherapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Embolotherapy Market Share by Region (2024-2029)
Table 18. Embolotherapy Market Trends
Table 19. Embolotherapy Market Drivers
Table 20. Embolotherapy Market Challenges
Table 21. Embolotherapy Market Restraints
Table 22. Global Top Embolotherapy Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Embolotherapy Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Embolotherapy Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Embolotherapy, Headquarters and Area Served
Table 26. Global Embolotherapy Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Embolotherapy by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Embolotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Embolotherapy Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Embolotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Embolotherapy Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Embolotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Embolotherapy Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Embolotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Embolotherapy Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Embolotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Embolotherapy Market Size by Country (2024-2029) & (US$ Million)
Table 45. Medtronic Company Detail
Table 46. Medtronic Business Overview
Table 47. Medtronic Embolotherapy Product
Table 48. Medtronic Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 49. Medtronic Recent Development
Table 50. Boston Scientific Company Detail
Table 51. Boston Scientific Business Overview
Table 52. Boston Scientific Embolotherapy Product
Table 53. Boston Scientific Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 54. Boston Scientific Recent Development
Table 55. Terumo Company Detail
Table 56. Terumo Business Overview
Table 57. Terumo Embolotherapy Product
Table 58. Terumo Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 59. Terumo Recent Development
Table 60. Penumbra, Inc. Company Detail
Table 61. Penumbra, Inc. Business Overview
Table 62. Penumbra, Inc. Embolotherapy Product
Table 63. Penumbra, Inc. Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 64. Penumbra, Inc. Recent Development
Table 65. Johnson & Johnson Company Detail
Table 66. Johnson & Johnson Business Overview
Table 67. Johnson & Johnson Embolotherapy Product
Table 68. Johnson & Johnson Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 69. Johnson & Johnson Recent Development
Table 70. Sirtex Company Detail
Table 71. Sirtex Business Overview
Table 72. Sirtex Embolotherapy Product
Table 73. Sirtex Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 74. Sirtex Recent Development
Table 75. Merit Medical Company Detail
Table 76. Merit Medical Business Overview
Table 77. Merit Medical Embolotherapy Product
Table 78. Merit Medical Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 79. Merit Medical Recent Development
Table 80. Varian Company Detail
Table 81. Varian Business Overview
Table 82. Varian Embolotherapy Product
Table 83. Varian Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 84. Varian Recent Development
Table 85. Stryker Company Detail
Table 86. Stryker Business Overview
Table 87. Stryker Embolotherapy Product
Table 88. Stryker Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 89. Stryker Recent Development
Table 90. Jiangsu Hengrui Pharmaceuticals Co., Ltd Company Detail
Table 91. Jiangsu Hengrui Pharmaceuticals Co., Ltd Business Overview
Table 92. Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Product
Table 93. Jiangsu Hengrui Pharmaceuticals Co., Ltd Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 94. Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Development
Table 95. Cook Medical Company Detail
Table 96. Cook Medical Business Overview
Table 97. Cook Medical EmbolotherapyProduct
Table 98. Cook Medical Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 99. Cook Medical Recent Development
Table 100. Kaneka Company Detail
Table 101. Kaneka Business Overview
Table 102. Kaneka EmbolotherapyProduct
Table 103. Kaneka Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 104. Kaneka Recent Development
Table 105. Meril Life Sciences Company Detail
Table 106. Meril Life Sciences Business Overview
Table 107. Meril Life Sciences EmbolotherapyProduct
Table 108. Meril Life Sciences Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 109. Meril Life Sciences Recent Development
Table 110. Peijia Medical Limited Company Detail
Table 111. Peijia Medical Limited Business Overview
Table 112. Peijia Medical Limited EmbolotherapyProduct
Table 113. Peijia Medical Limited Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 114. Peijia Medical Limited Recent Development
Table 115. Wallaby Medical Company Detail
Table 116. Wallaby Medical Business Overview
Table 117. Wallaby Medical EmbolotherapyProduct
Table 118. Wallaby Medical Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 119. Wallaby Medical Recent Development
Table 120. MicroPort Scientific Corporation Company Detail
Table 121. MicroPort Scientific Corporation Business Overview
Table 122. MicroPort Scientific Corporation EmbolotherapyProduct
Table 123. MicroPort Scientific Corporation Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 124. MicroPort Scientific Corporation Recent Development
Table 125. Shandong Visee Medical Devices Co.,Ltd Company Detail
Table 126. Shandong Visee Medical Devices Co.,Ltd Business Overview
Table 127. Shandong Visee Medical Devices Co.,Ltd EmbolotherapyProduct
Table 128. Shandong Visee Medical Devices Co.,Ltd Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 129. Shandong Visee Medical Devices Co.,Ltd Recent Development
Table 130. Beijing Taijie Weiye Technology Company Detail
Table 131. Beijing Taijie Weiye Technology Business Overview
Table 132. Beijing Taijie Weiye Technology EmbolotherapyProduct
Table 133. Beijing Taijie Weiye Technology Revenue in Embolotherapy Business (2017-2022) & (US$ Million)
Table 134. Beijing Taijie Weiye Technology Recent Development
Table 135. Medtronic Company Information
Table 136. Medtronic Business Overview
Table 137. Medtronic Embolotherapy Revenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 138. Medtronic Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 139. Medtronic Recent Development
Table 140. Boston Scientific Company Information
Table 141. Boston Scientific Business Overview
Table 142. Boston Scientific Embolotherapy Revenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 143. Boston Scientific Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 144. Boston Scientific Recent Development
Table 145. Terumo Company Information
Table 146. Terumo Business Overview
Table 147. Terumo Embolotherapy Revenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 148. Terumo Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 149. Terumo Recent Development
Table 150. Penumbra, Inc. Company Information
Table 151. Penumbra, Inc. Business Overview
Table 152. Penumbra, Inc. Embolotherapy Revenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 153. Penumbra, Inc. Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 154. Penumbra, Inc. Recent Development
Table 155. Johnson & Johnson Company Information
Table 156. Johnson & Johnson Business Overview
Table 157. Johnson & Johnson Embolotherapy Revenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 158. Johnson & Johnson Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 159. Johnson & Johnson Recent Development
Table 160. Sirtex Company Information
Table 161. Sirtex Business Overview
Table 162. Sirtex Embolotherapy Revenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 163. Sirtex Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 164. Sirtex Recent Development
Table 165. Merit Medical Company Information
Table 166. Merit Medical Business Overview
Table 167. Merit Medical Embolotherapy Revenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 168. Merit Medical Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 169. Merit Medical Recent Development
Table 170. Varian Company Information
Table 171. Varian Business Overview
Table 172. Varian Embolotherapy Revenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 173. Varian Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 174. Varian Recent Development
Table 175. Stryker Company Information
Table 176. Stryker Business Overview
Table 177. Stryker Embolotherapy Revenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 178. Stryker Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 179. Stryker Recent Development
Table 180. Jiangsu Hengrui Pharmaceuticals Co., Ltd Company Information
Table 181. Jiangsu Hengrui Pharmaceuticals Co., Ltd Business Overview
Table 182. Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Revenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 183. Jiangsu Hengrui Pharmaceuticals Co., Ltd Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 184. Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Development
Table 185. Cook Medical Company Information
Table 186. Cook Medical Business Overview
Table 187. Cook Medical EmbolotherapyRevenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 188. Cook Medical Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 189. Cook Medical Recent Development
Table 190. Kaneka Company Information
Table 191. Kaneka Business Overview
Table 192. Kaneka EmbolotherapyRevenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 193. Kaneka Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 194. Kaneka Recent Development
Table 195. Meril Life Sciences Company Information
Table 196. Meril Life Sciences Business Overview
Table 197. Meril Life Sciences EmbolotherapyRevenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 198. Meril Life Sciences Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 199. Meril Life Sciences Recent Development
Table 200. Peijia Medical Limited Company Information
Table 201. Peijia Medical Limited Business Overview
Table 202. Peijia Medical Limited EmbolotherapyRevenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 203. Peijia Medical Limited Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 204. Peijia Medical Limited Recent Development
Table 205. Wallaby Medical Company Information
Table 206. Wallaby Medical Business Overview
Table 207. Wallaby Medical EmbolotherapyRevenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 208. Wallaby Medical Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 209. Wallaby Medical Recent Development
Table 210. MicroPort Scientific Corporation Company Information
Table 211. MicroPort Scientific Corporation Business Overview
Table 212. MicroPort Scientific Corporation EmbolotherapyRevenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 213. MicroPort Scientific Corporation Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 214. MicroPort Scientific Corporation Recent Development
Table 215. Shandong Visee Medical Devices Co.,Ltd Company Information
Table 216. Shandong Visee Medical Devices Co.,Ltd Business Overview
Table 217. Shandong Visee Medical Devices Co.,Ltd EmbolotherapyRevenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 218. Shandong Visee Medical Devices Co.,Ltd Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
Table 219. Shandong Visee Medical Devices Co.,Ltd Recent Development
Table 220. Beijing Taijie Weiye Technology Company Information
Table 221. Beijing Taijie Weiye Technology Business Overview
Table 222. Beijing Taijie Weiye Technology EmbolotherapyRevenue in Embolotherapy Business (2018-2023) & (US$ Million)
Table 223. Beijing Taijie Weiye Technology Revenue in Embolotherapy Business (2018-2023) & (US$ Million) Portfolio
